{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:50:39Z","timestamp":1762091439158,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110596","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T10:46:18Z","timestamp":1689072378000},"page":"110596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of COVID-19 inactivated vaccine on peripheral blood anti-\u03b22-GPI antibody and outcomes in vitro fertilization-embryo transplantation"],"prefix":"10.1016","volume":"122","author":[{"given":"Huiling","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-9395","authenticated-orcid":false,"given":"Qicai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110596_b0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/joim.13126","article-title":"High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?","volume":"289","author":"Pineton de Chambrun","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2023.110596_b0010","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"15","author":"Borghi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110596_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-021-01029-3","article-title":"Systematic review of antiphospholipid antibodies in COVID-19 patients: culprits or bystanders?","volume":"23","author":"Foret","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.intimp.2023.110596_b0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood-2012-03-378646","article-title":"The significance of autoantibodies against \u03b22-glycoprotein I","volume":"120","author":"De Groot","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.intimp.2023.110596_b0025","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/14767058.2018.1535586","article-title":"In vitro fertilization outcomes in women with antiphospholipid antibodies circulation","volume":"33","author":"Khizroeva","year":"2020","journal-title":"J. Matern Fetal Neonatal. Med."},{"key":"10.1016\/j.intimp.2023.110596_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2022.112294","article-title":"Vaccination games in prevention of infectious diseases with application to COVID-19","volume":"161","author":"Ge","year":"2022","journal-title":"Chaos Solitons Fractals."},{"key":"10.1016\/j.intimp.2023.110596_b0035","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1002\/jmv.28012","article-title":"Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection","volume":"94","author":"Wang","year":"2022","journal-title":"J. Med.Virol."},{"key":"10.1016\/j.intimp.2023.110596_b0040","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"Alpha scientists in reproductive medicine and ESHRE special interest group of embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","author":"Balaban","year":"2011","journal-title":"Hum Reprod."},{"key":"10.1016\/j.intimp.2023.110596_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12978-022-01558-9","article-title":"The influence of male and female overweight\/obesity on IVF outcomes: a cohort study based on registration in Western China","volume":"20","author":"Liu","year":"2023","journal-title":"Reprod. Health."},{"key":"10.1016\/j.intimp.2023.110596_b0050","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3390\/jcm10132902","article-title":"ISIDOG consensus guidelines on COVID-19 vaccination for women before, during and after pregnancy","volume":"10","author":"Donders","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.intimp.2023.110596_b0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2147\/JIR.S347729","article-title":"No effect of inactivated SARS-CoV-2 vaccination on in vitro fertilization outcomes: A propensity score-matched study","volume":"9","author":"Huang","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2023.110596_b0060","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10815-022-02543-8","article-title":"Effects of COVID-19 vaccination status, vaccine type, and vaccination interval on IVF pregnancy outcomes in infertile couples","volume":"39","author":"Dong","year":"2022","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.intimp.2023.110596_b0065","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.fertnstert.2009.01.089","article-title":"Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss","volume":"93","author":"Alijotas-Reig","year":"2010","journal-title":"Fertil Steril."},{"key":"10.1016\/j.intimp.2023.110596_b0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.thromres.2004.06.035","article-title":"Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies","volume":"114","author":"Tincani","year":"2004","journal-title":"Thromb Res."},{"key":"10.1016\/j.intimp.2023.110596_b0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/jcm10040869","article-title":"Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art","volume":"10","author":"Vomstein","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2023.110596_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12522-014-0196-y","article-title":"The role of antiphospholipid antibodies (aPLs) in infertile women: the long-lasting experience","volume":"14","author":"Ulcova-Gallova","year":"2014","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.intimp.2023.110596_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103251","article-title":"Platelet-activating factor and antiphospholipid antibodies in recurrent implantation failure","volume":"143","author":"Mahdian","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.intimp.2023.110596_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13470","article-title":"Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: A systematic review and meta-analysis","volume":"86","author":"Gao","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.intimp.2023.110596_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/314704","article-title":"Antiphospholipid antibodies in women undergoing in vitro fertilization treatment: clinical value of IgA anti-\u03b22 glycoprotein I antibodies determination","volume":"2014","author":"Paulmyer-Lacroix","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2023.110596_b0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12872-019-1135-y","article-title":"A cute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report\u202f: Anticardiolipin antibody and myocardial infarction","volume":"19","author":"Su","year":"2019","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.intimp.2023.110596_b0105","article-title":"Cytomegalovirus-associated venous and arterial thrombotic disease","volume":"12","author":"Kelkar","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.intimp.2023.110596_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102822","article-title":"Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent","volume":"20","author":"Vollmer","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2023.110596_b0115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"Kanduc","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2023.110596_b0120","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/ijms23031716","article-title":"SARS-CoV-2 specific immune response and the pathogenesis of COVID-19","volume":"23","author":"Gusev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110596_b0125","first-page":"2040","article-title":"SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients","volume":"18","author":"Deng","year":"2021","journal-title":"CellMol Immunol."},{"key":"10.1016\/j.intimp.2023.110596_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125228","article-title":"Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo","volume":"10","author":"Stoel","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.intimp.2023.110596_b0135","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fimmu.2019.01081","article-title":"HLA-Class II artificial antigen presenting cells in CD4+ T cell-based immunotherapy","volume":"17","author":"Couture","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2023.110596_b0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat. Rev.Immunol."},{"key":"10.1016\/j.intimp.2023.110596_b0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.60.5.500","article-title":"Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections","volume":"60","author":"Guglielmone","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2023.110596_b0150","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s42399-021-00992-3","article-title":"Untangling the intricacies of infection, thrombosis, vaccination, and antiphospholipid antibodies for COVID-19","volume":"3","author":"Cimolai","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"10.1016\/j.intimp.2023.110596_b0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.62.5.388","article-title":"Antiphospholipid antibodies and infections","volume":"62","author":"Asherson","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2023.110596_b0160","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s10067-021-05724-5","article-title":"Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?","volume":"40","author":"Castillo-Mart\u00ednez","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110596_b0165","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/jth.14994","article-title":"Antiphospholipid antibodies in patients with COVID-19: a relevant observation?","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2023.110596_b0170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-0037-1603936","article-title":"Prevalence and thrombotic risk assessment of anti-\u03b22 glycoprotein I domain I antibodies: a systematic review","volume":"44","author":"Radin","year":"2018","journal-title":"Semin Thromb. Hemost."},{"key":"10.1016\/j.intimp.2023.110596_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2018.02.002","article-title":"Beyond thrombosis: anti-\u03b22GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome","volume":"90","author":"Chighizola","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.110596_b0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0961203319893763","article-title":"Antiphospholipid syndrome and infertility","volume":"29","author":"El Hasbani","year":"2020","journal-title":"Lupus."},{"key":"10.1016\/j.intimp.2023.110596_b0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-019-0805-1","article-title":"Brief report on the 11th meeting of the European Forum on antiphospholipid antibodies","volume":"21","author":"Chayou\u00e2","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.intimp.2023.110596_b0190","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.autrev.2012.11.008","article-title":"Correct laboratory approach to APS diagnosis and monitoring","volume":"12","author":"Pengo","year":"2013","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.intimp.2023.110596_b0195","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00296-019-04318-4","article-title":"Anti-phospholipid antibody syndrome occurrence in patients with persistent anti-phospholipid antibodies","volume":"39","author":"Choi","year":"2019","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.intimp.2023.110596_b0200","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acr.20098","article-title":"Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome","volume":"62","author":"Ruffatti","year":"2010","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.intimp.2023.110596_b0205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.autrev.2014.12.010","article-title":"(EUROAPS Study Group Collaborators). The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases","volume":"14","author":"Alijotas-Reig","year":"2015","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.intimp.2023.110596_b0210","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.intimp.2023.110596_b0215","article-title":"Common autoimmune antibodies in unexplained infertile female patients in Saudi Arabia","volume":"14","author":"Koshak","year":"2022","journal-title":"Cureus."},{"key":"10.1016\/j.intimp.2023.110596_b0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1196\/annals.1422.048","article-title":"Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization","volume":"1108","author":"Sanmarco","year":"2007","journal-title":"Ann. N Y Acad. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:23:37Z","timestamp":1736432617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":44,"alternative-id":["S1567576923009219"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110596","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of COVID-19 inactivated vaccine on peripheral blood anti-\u03b22-GPI antibody and outcomes in vitro fertilization-embryo transplantation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110596"}}